• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根除治疗对免疫性血小板减少症患者的影响:中东地区开展的研究的荟萃分析

Effect of eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East.

作者信息

Pezeshki Seyed Mohammad Sadegh, Saki Najmadin, Ghandali Mehran Varnaseri, Ekrami Alireza, Avarvand Arshid Yousefi

机构信息

Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.

Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Blood Res. 2021 Mar 31;56(1):38-43. doi: 10.5045/br.2021.2020189.

DOI:10.5045/br.2021.2020189
PMID:33707351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987475/
Abstract

BACKGROUND

Immune thrombocytopenia (ITP) is a bleeding disorder. is a Gram-negative bacterium that is presumed to be associated with ITP and therapeutic response of patients. To evaluate the effect of eradication on platelet count of ITP patients, we analyzed the studies conducted on the association between infection and response to therapy in ITP patients in Western Asia focusing on the Middle East region.

METHODS

A systematic search of databases (PubMed/Medline, ISI Web of Science, Cochrane Central) and Google Scholar search engine results was conducted up until January 2020. The keywords included in the search were and/or , ITP and/or immune thrombocytopenia.

RESULTS

Seven studies comprising a total of 228 patients (193 with successful eradication) were included in this study. The association between eradication and ITP was expressed as odds ratios (OR) and 95% confidence intervals (CI). The findings showed that patients who received eradication treatment for infection had significantly higher OR (OR, 8.83; 95% CI, 2.03‒38.35; =0.004) than those in the non-eradicated group.

CONCLUSION

Our results indicate a significant therapeutic effect of eradication on the platelet count of patients with chronic ITP. Given the inherent limitations of this study, including the small number of patients, further studies with more patients are recommended.

摘要

背景

免疫性血小板减少症(ITP)是一种出血性疾病。[某种细菌名称]是一种革兰氏阴性菌,被认为与ITP及患者的治疗反应有关。为评估根除[该细菌]对ITP患者血小板计数的影响,我们分析了在西亚尤其是中东地区开展的关于[该细菌]感染与ITP患者治疗反应之间关联的研究。

方法

截至2020年1月,对数据库(PubMed/Medline、ISI Web of Science、Cochrane Central)和谷歌学术搜索引擎结果进行了系统检索。检索中使用的关键词包括[该细菌名称]和/或[相关术语]、ITP和/或免疫性血小板减少症。

结果

本研究纳入了7项研究,共228例[该细菌]患者(193例成功根除)。根除[该细菌]与ITP之间的关联以比值比(OR)和95%置信区间(CI)表示。结果显示,接受[该细菌]感染根除治疗的患者的OR显著高于未根除组(OR,8.83;95%CI,2.03‒38.35;P = 0.004)。

结论

我们的结果表明,根除[该细菌]对慢性ITP患者的血小板计数有显著治疗效果。鉴于本研究存在固有局限性,包括患者数量较少,建议开展更多患者参与的进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/7987475/2f2f00c3d582/br-56-1-38-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/7987475/231acca2adfa/br-56-1-38-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/7987475/14f672345ec3/br-56-1-38-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/7987475/2f2f00c3d582/br-56-1-38-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/7987475/231acca2adfa/br-56-1-38-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/7987475/14f672345ec3/br-56-1-38-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/7987475/2f2f00c3d582/br-56-1-38-f3.jpg

相似文献

1
Effect of eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East.根除治疗对免疫性血小板减少症患者的影响:中东地区开展的研究的荟萃分析
Blood Res. 2021 Mar 31;56(1):38-43. doi: 10.5045/br.2021.2020189.
2
Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study.序贯根除幽门螺杆菌治疗伴有中度血小板减少的免疫性血小板减少症:一项多中心前瞻性随机 3 期研究。
Ann Hematol. 2022 Jul;101(7):1435-1445. doi: 10.1007/s00277-022-04782-2. Epub 2022 May 28.
3
Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials.特发性血小板减少性紫癜的根除治疗:随机试验的荟萃分析
Gastroenterol Res Pract. 2018 Oct 9;2018:6090878. doi: 10.1155/2018/6090878. eCollection 2018.
4
Management of Helicobacter pylori in Patients with Immune Thrombocytopenia.免疫性血小板减少症患者的幽门螺杆菌管理。
Hamostaseologie. 2019 Aug;39(3):279-283. doi: 10.1055/s-0039-1683974. Epub 2019 Mar 19.
5
Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.根除疗法作为幽门螺杆菌阳性的特发性血小板减少性紫癜的一线治疗方法是否有用?对日本207例已根除幽门螺杆菌的慢性免疫性血小板减少症病例的分析。
Int J Hematol. 2005 Feb;81(2):162-8. doi: 10.1532/ijh97.04146.
6
Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review.幽门螺杆菌根除治疗真的能改善特发性血小板减少性紫癜的血小板减少情况吗?我们的经验及文献综述
Int J Hematol. 2003 Apr;77(3):239-44. doi: 10.1007/BF02983780.
7
Helicobacter pylori infection and idiopathic thrombocytopenic purpura.幽门螺杆菌感染与特发性血小板减少性紫癜
Int J Hematol. 2005 Feb;81(2):113-8. doi: 10.1532/ijh97.04161.
8
Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.幽门螺杆菌感染性胃炎的特征以及幽门螺杆菌根除对慢性特发性血小板减少性紫癜患者的影响。
Helicobacter. 2004 Oct;9(5):443-52. doi: 10.1111/j.1083-4389.2004.00261.x.
9
Clinical characteristics and treatment outcomes in patients with Helicobacter pylori-positive chronic immune thrombocytopenic purpura.幽门螺杆菌阳性慢性免疫性血小板减少性紫癜患者的临床特征及治疗结果
Platelets. 2014;25(7):548-51. doi: 10.3109/09537104.2013.841883. Epub 2013 Oct 31.
10
Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies.幽门螺杆菌与免疫性血小板减少性紫癜:未解决的问题与争议
Int J Hematol. 2006 Nov;84(4):309-15. doi: 10.1532/IJH97.06188.

引用本文的文献

1
Impact of Infection upon the Evolution and Outcome of Pediatric Immune Thrombocytopenic Purpura: A Comprehensive Review.感染对儿童免疫性血小板减少性紫癜的演变及结局的影响:一项综述
Diagnostics (Basel). 2023 Oct 13;13(20):3205. doi: 10.3390/diagnostics13203205.
2
Gastric troubles in Iran: The role of social and economic factors in infection.伊朗的胃部疾病:社会和经济因素在感染中的作用。
Health Promot Perspect. 2023 Jul 10;13(2):120-128. doi: 10.34172/hpp.2023.15. eCollection 2023.
3
Predictor Factors for Chronicity in Immune Thrombocytopenic Purpura in Children.

本文引用的文献

1
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.幽门螺杆菌:当前诊断与管理策略综述。
Dig Dis Sci. 2020 Jul;65(7):1917-1931. doi: 10.1007/s10620-020-06193-7.
2
Long-term follow-up of reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study.初始根除后再感染及其危险因素的长期随访:一项大规模多中心、前瞻性开放队列、观察性研究。
Emerg Microbes Infect. 2020 Mar 11;9(1):548-557. doi: 10.1080/22221751.2020.1737579. eCollection 2020.
3
Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision.
儿童免疫性血小板减少性紫癜慢性化的预测因素
Children (Basel). 2023 May 23;10(6):911. doi: 10.3390/children10060911.
4
Infection and Chronic Immune Thrombocytopenia.感染与慢性免疫性血小板减少症
J Clin Med. 2022 Aug 17;11(16):4822. doi: 10.3390/jcm11164822.
5
induced Immune Thrombocytopenic Purpura and perspective role of eradication therapy for treating Immune Thrombocytopenic Purpura.免疫性血小板减少性紫癜与根除疗法在治疗免疫性血小板减少性紫癜中的潜在作用
AIMS Microbiol. 2021 Sep 2;7(3):284-303. doi: 10.3934/microbiol.2021018. eCollection 2021.
6
Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand.澳大利亚和新西兰成人免疫性血小板减少症管理共识指南。
Med J Aust. 2022 Jan 17;216(1):43-52. doi: 10.5694/mja2.51284. Epub 2021 Oct 10.
7
Rescue Therapies for Infection in Italy.意大利感染的挽救疗法
Antibiotics (Basel). 2021 May 3;10(5):525. doi: 10.3390/antibiotics10050525.
日本成人免疫性血小板减少症管理参考指南:2019年修订版
Int J Hematol. 2020 Mar;111(3):329-351. doi: 10.1007/s12185-019-02790-z. Epub 2020 Jan 2.
4
Primary Immune Thrombocytopenia: A Translational Research Model for Autoimmune Diseases.原发性免疫性血小板减少症:自身免疫性疾病的转化研究模型
J Clin Med. 2019 Nov 14;8(11):1971. doi: 10.3390/jcm8111971.
5
Helicobacter pylori: An Underrated Cause of Immune Thrombocytopenic Purpura. A Comprehensive Review.幽门螺杆菌:免疫性血小板减少性紫癜的一个被低估的病因。一篇综述。
Cureus. 2019 Sep 1;11(9):e5551. doi: 10.7759/cureus.5551.
6
Immune Thrombocytopenia.免疫性血小板减少症
N Engl J Med. 2019 Sep 5;381(10):945-955. doi: 10.1056/NEJMcp1810479.
7
HLA-B5, 7, 8, 27, and 51 Antigens and Immune Thrombocytopenic Purpura: Is There an Association?HLA - B5、7、8、27和51抗原与免疫性血小板减少性紫癜:存在关联吗?
J Pediatr Hematol Oncol. 2020 Jan;42(1):e32-e37. doi: 10.1097/MPH.0000000000001543.
8
Involvement of Interferon-γ + 874A/T Polymorphism in the Pathogenesis of and Therapeutic Response to Immune Thrombocytopenia.干扰素-γ +874A/T多态性与免疫性血小板减少症发病机制及治疗反应的相关性
Lab Med. 2019 Jul 16;50(3):e42-e49. doi: 10.1093/labmed/lmz010.
9
HLAs in Autoimmune Diseases: Dependable Diagnostic Biomarkers?自身免疫性疾病中的人类白细胞抗原:可靠的诊断生物标志物?
Curr Rheumatol Rev. 2019;15(4):269-276. doi: 10.2174/1573397115666190115143226.
10
The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT.人类白细胞抗原与免疫性血小板减少症、血栓性血小板减少性紫癜及肝素诱导的血小板减少症之间的关联
J Pediatr Hematol Oncol. 2019 Mar;41(2):81-86. doi: 10.1097/MPH.0000000000001381.